BioStar Ventures III, L.P.
CIK 1577164 · View on SEC EDGAR ↗
First SEC filing: Feb. 1, 2024 · Latest: Feb. 1, 2024
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 18, 2024 | AMIX | P | 1,088,000 | $0.03 | $32,640 | 1,088,000 Direct | — | Acquired | -56.9% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 18, 2024 | AMIX | Warrant to Purchase Common Stock | Common Stock (1,088,000) | $0.00 | Jan. 29, 2029 | 1,088,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Feb. 1, 2024 | AMIX | Common Stock | 2,416,305 | Direct |